Myra Vision’s Post

#Publicationalert Glad to share our recent publication in the British Journal of Ophthalmology! We have shared interesting results on the adjuvant role of topical cyclosporine 1% in acute Stevens-Johnson syndrome. Check out the latest insights in ophthalmology research! #Ophthalmology #ResearchPublication PS- Feels good to be back in research!

Surendra Basti, MD, Manjot K. Gill, MD, and Angelo P. Tanna, MD, of Northwestern Medicine Ophthalmology, share what you need to know from AAO 2024. Listen to the full recap here: https://lnkd.in/eVDf-_xc

Functional outcome is one of the things we need to emphasize apart from anatomical reattachment in rrd surgery. This study highlighted what we can look for to achieve good functional vision post operative.

A great article discussing with Prof Barrett the genesis and realisation of the RayOne EMV IOL, and his stellar career in Ophthalmology more widely. 5mins of your time well spent!

Finally, Altris AI is going to American Academy of Ophthalmology main event in 2024 in Chicago. ✅ Dear American colleagues, I will be happy to meet you at Booth 4058 to show you Altris AI and discuss how Artificial Intelligence for OCT scan analysis is changing the game in Ophthalmology. Any tips for visiting American Academy of Ophthalmology event?

🌍 𝗪𝗼𝗿𝗹𝗱 𝗦𝗶𝗴𝗵𝘁 𝗗𝗮𝘆 𝟮𝟬𝟮𝟰 this year is drawing attention to the importance of eye care, especially for young people, and inspiring children everywhere to love their eyes. Here are a few but powerful actions that can help educate and raise awareness about the importance of maintaining healthy vision. 1.      𝗘𝗻𝗰𝗼𝘂𝗿𝗮𝗴𝗲 𝗥𝗲𝗴𝘂𝗹𝗮𝗿 𝗘𝘆𝗲 𝗘𝘅𝗮𝗺𝘀: Remind friends and family to schedule routine eye exams, as early detection of vision issues can prevent long-term problems. 2.      𝗣𝗿𝗼𝗺𝗼𝘁𝗲 𝗛𝗲𝗮𝗹𝘁𝗵𝘆 𝗦𝗰𝗿𝗲𝗲𝗻 𝗛𝗮𝗯𝗶𝘁𝘀: Share the importance of taking breaks, practising the 20-20-20 rule (every 20 minutes, look at something 20 feet away for 20 seconds), and adjusting screen brightness to reduce eye strain. 3.      𝗘𝗱𝘂𝗰𝗮𝘁𝗲 𝗼𝗻 𝗨𝗩 𝗣𝗿𝗼𝘁𝗲𝗰𝘁𝗶𝗼𝗻: Advocate for wearing sunglasses that block 100% of UV rays, even on cloudy days, to protect eyes from harmful sun exposure. 4.      𝗠𝗮𝗶𝗻𝘁𝗮𝗶𝗻 𝗮 𝗕𝗮𝗹𝗮𝗻𝗰𝗲𝗱 𝗗𝗶𝗲𝘁: Promote a diet rich in nutrients like Vitamin A, Omega-3 fatty acids, and antioxidants, which are essential for maintaining good eye health. 5.      𝗣𝗿𝗮𝗰𝘁𝗶𝗰𝗲 𝗚𝗼𝗼𝗱 𝗛𝘆𝗴𝗶𝗲𝗻𝗲 𝘄𝗶𝘁𝗵 𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗟𝗲𝗻𝘀𝗲𝘀: Remind contact lens wearers to follow proper cleaning and storage procedures to avoid infections and complications. 6.      𝗥𝗮𝗶𝘀𝗲 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗮𝗯𝗼𝘂𝘁 𝗘𝘆𝗲 𝗦𝗮𝗳𝗲𝘁𝘆: Encourage the use of protective eye wear during sports, hobbies, or work that may expose the eyes to harmful particles or injuries. 7.      𝗗𝗶𝘀𝗰𝘂𝘀𝘀 𝘁𝗵𝗲 𝗜𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝗰𝗲 𝗼𝗳 𝗘𝘆𝗲-𝗙𝗿𝗶𝗲𝗻𝗱𝗹𝘆 𝗟𝗶𝗴𝗵𝘁𝗶𝗻𝗴: Proper lighting at home or work can reduce strain, so share tips on creating an eye-friendly environment with well-lit spaces. 8.      𝗧𝗲𝗮𝗰𝗵 𝗖𝗵𝗶𝗹𝗱𝗿𝗲𝗻 𝗔𝗯𝗼𝘂𝘁 𝗘𝘆𝗲 𝗛𝗲𝗮𝗹𝘁𝗵: Make eye care fun and engaging for kids by teaching them about the importance of not rubbing their eyes and using safe screen time habits. 👀 𝗧𝗮𝗸𝗲 𝗖𝗮𝗿𝗲 𝗼𝗳 𝗬𝗼𝘂𝗿 𝗩𝗶𝘀𝗶𝗼𝗻!

Healthcare cybersecurity has never been more critical, with the risks to patient safety and business continuity growing every day. At MyRxWallet, we understand the urgency of this challenge and are fully equipped to transform healthcare cybersecurity. Our blockchain-powered platform and tamper-proof technology ensure that patient data remains secure and immutable, virtually eliminating the threat of unauthorized access or data manipulation. With AI-driven monitoring, we offer real-time protection, detecting and neutralizing threats before they cause harm. By decentralizing data management through our Web3 infrastructure, we prevent single points of failure, dramatically reducing the risk of breaches that can compromise entire systems. At MyRxWallet, we’re not just meeting the moment; we’re redefining healthcare cybersecurity for the future. With our solutions, providers can focus on delivering care, knowing their systems and patient data are secure. Let’s build a safer, more resilient healthcare infrastructure—together. #Cybersecurity #HealthcareInnovation #Blockchain #AI #DataSecurity #Web3 #MyRxWallet #HealthcareTransformation

✨ Exciting News! ✨ I'm delighted to share the publication of my latest article titled "Shedding Light on Congenital Aniridia: An In-depth Study of Two Cases" in JFO Open Ophthalmology. This work explores the complexities of congenital aniridia through two detailed case studies, contributing valuable insights to the field of ophthalmology. I'm grateful to the editorial team and reviewers for their guidance throughout the publication process. A special thanks to my colleagues and mentors who supported this endeavour. I hope this article will serve as a helpful resource for clinicians and researchers interested in rare ocular conditions. 💻 Access the article here: https://lnkd.in/eDUs6Us5 #Ophthalmology #ResearchPublication #CongenitalAniridia #OcularGenetics #OpenAccess

AAO Chicago, you are next up! Looking forward to seeing all of my friends and colleagues in the "Windy City" for a look at the latest and greatest across Ophthalmology. If you'll be in town and want to connect let me know! #AAO #Ophthalmology #Optometry #ConferenceSeason #MJHLifeSciences #OphthalmologyTimes #ModernRetina #OptometryTimes

Thanks to Dr. Rosetta Pietro for this opportunity and to Dr Gianmaria Barone and Francesco Santoru for their precious collaboration in publishing this study conducted at the Department of Ophthalmology, Humanitas San Pio X, Milan. The study evaluates the outcomes of transepithelial iontophoresis cross-linking (I-CXL) in managing early keratoconus in patients under 25. 📊 Key Findings: - **Patient Profile:** High visual acuity (LogMAR ≤ 0.2) and early keratoconus treated with I-CXL. - **Outcome Stability:** After a 24-month follow-up, no significant changes in key metrics such as CDVA, keratometry, or corneal thickness were observed. - **Safety and Effectiveness:** None of the patients exhibited keratoconus progression during the follow-up period. - **Potential Benefits:** I-CXL emerges as a minimally invasive option for less advanced patients, offering an alternative to standard epithelium-off CXL.